This systematic review and meta-analysis evaluates long-term survival outcomes by number of immune checkpoint inhibitors among patients with programmed death-ligand 1 (PD-L1)–negative non–small cell lung cancer (NSCLC).
LIVE WEBINAR: Wednesday, February 19, 2025 | 5:00 PM – 6:00 PM Eastern Time (ET) Register for this complimentary event with the “Register Now” button…
Maternal platelet-activating anti–platelet factor 4 antibodies led to cerebral venous sinus thrombosis, thrombocytopenia, hyperfibrinolysis, and cerebral bleeding in a neonate.
Military families protesting the defense department’s anti-DEI push heckled Defense Secretary Hegseth at United States European Command headquarters in Germany.
First-line 177Lu-Dotatate plus octreotide LAR significantly extended median progression-free survival (by 14 months) in patients with grade 2 or 3 advanced gastroenteropancreatic neuroendocrine tumours. 177Lu-Dotatate…
PURPOSEImmune checkpoint inhibitors (ICIs) have revolutionized the care of patients with cancer, but use among hospitalized patients is controversial as a result of questionable benefit…
Duke Cancer Institute Center for Prostate and Urologic Cancers has embraced multidisciplinary care for over 20 years.
This paper explores the meaning of the term “sex” in law. It distinguishes between indeterminate sex and attempts to change sex, by tracing caselaw of
For more than 60 years, the MMWR has published life-saving information on U.S. public health crises. The Trump administration’s pause on health communications has disrupted…
Arun Azad Department of Medical Oncology, Peter MacCallum Cancer Centre Arun Azad , Ding-Wei Ye , Hiroji Uemura , Amitabha Bhaumik , Michael Eisbacher ,…
Wafik S. El-Deiry: We’ve led the way for decades and it’s vital to do so moving into the future / cancer, OncoDaily, Oncology, Wafik S.…
